Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
 

_____ Brought to you by Unchained Labs _____

Rapid Expansion of Data-driven Chemical Development Through the Combination of Laboratory Automation, DoE and Modeling Techniques

REGISTER NOW

 

  September 25, 2018

  8:00 a.m. PDT / 11:00 a.m. EDT / 16:00 BST / 17:00 CEST

 

Overview

 

The design, development and implementation of a robust, predictable, and scalable manufacturing process is the key outcome of chemical development. In chemical development, laboratory automation plays an important role—enabling the collection of large experimental arrays directed towards the discovery and optimization of process conditions that yield robust, predictable, and scalable manufacturing processes. To take a relevant example, rationally-designed and automatically-executed experiments can be used to accelerate the discovery of new reactions and build unprecedented understanding around chemical reaction dynamics. Augmenting these experimental tools are new computational techniques in data science and machine learning that enable scientists and engineers to extract insight and models that inform process development. In this webinar, our speakers from Amgen and Bristol-Myers Squibb will discuss approaches to efficiently generate, and effectively utilize, chemical reaction data through automation and data-driven modeling.

In the first talk, Victor Rosso and Jacob Albrecht from Bristol-Myers Squibb will discuss how laboratory automation plays an important role in enabling the rapid identification and optimization of reaction conditions. Through specific examples, this presentation will highlight key aspects of the application of modern, automated technologies towards design of experiments (DoE) and the statistical modelling of their processes as they enter manufacturing environments. In the second talk, Dan Griffin from Amgen will describe how automation can be combined with new strategies for learning from data. Using a real-world example, this presentation will demonstrate how such an approach can accelerate chemical reaction modeling and optimization for mid-phase pharmaceutical process development. Combined, these presentations clearly outline a data-driven development paradigm that has advantages in both speed and cost-of-development.

Brought to you by:

 

Key Learning Objectives

  • Learn how to use lab automation to enable rapid identification and optimization of reaction conditions.
  • See case studies of how automation can be used with DoE and statistical modeling.
  • See real-world examples of how to accelerate chemical reaction modeling and optimization for process development

Who Should Attend

  • Researchers/ R&D Managers
  • Laboratory Managers/ Directors / Supervisors
  • Laboratory Technicians / Operators
 

Speakers

Victor Rosso
Principal Scientist,
Bristol-Myers Squibb
Jake Albrecht,
Principal Scientist,
Bristol-Myers Squibb
Dan Griffin,
Senior Engineer,
Amgen
 

Moderator

Patricia Daukantas,
Contributing Writer,
C&EN Media Group
 

REGISTER NOW